Parmax Pharma Ltd

Parmax Pharma Ltd

₹ 29.1 -10.77%
05 Mar 11:49 a.m.
About

Incorporated in 1994, Parmax Pharma Ltd manufactures Bulk Drugs, Drug Intermediates & Speciality Chemicals.[1]

Key Points

Business Overview:[1]
PPL is engaged in the manufacture and supply
of bulk drugs (APIs) and selected formulations
catering primarily to the Indian pharma industry.

  • Market Cap 10.9 Cr.
  • Current Price 29.1
  • High / Low 55.0 / 28.0
  • Stock P/E
  • Book Value -12.9
  • Dividend Yield 0.00 %
  • ROCE -12.4 %
  • ROE %
  • Face Value 10.0

Pros

  • Debtor days have improved from 30.5 to 16.6 days.

Cons

  • Company has low interest coverage ratio.
  • Promoter holding is low: 30.8%

* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.

Loading peers table ...

Quarterly Results

Figures in Rs. Crores

Dec 2022 Mar 2023 Jun 2023 Sep 2023 Dec 2023 Mar 2024 Jun 2024 Sep 2024 Dec 2024 Mar 2025 Jun 2025 Sep 2025 Dec 2025
5.35 6.38 1.40 4.07 1.33 4.26 7.82 9.28 6.28 4.83 1.94 2.53 4.33
3.03 5.54 2.05 4.84 2.48 5.06 7.31 9.08 6.17 5.39 2.19 4.12 4.53
Operating Profit 2.32 0.84 -0.65 -0.77 -1.15 -0.80 0.51 0.20 0.11 -0.56 -0.25 -1.59 -0.20
OPM % 43.36% 13.17% -46.43% -18.92% -86.47% -18.78% 6.52% 2.16% 1.75% -11.59% -12.89% -62.85% -4.62%
0.01 0.01 0.01 0.01 0.01 0.01 0.01 0.12 0.01 -1.17 0.01 0.01 0.01
Interest 0.11 0.05 0.12 0.18 0.16 0.16 0.11 0.13 0.11 0.24 0.28 0.24 0.28
Depreciation 0.48 0.47 0.42 0.43 0.45 0.41 0.40 0.40 0.41 -0.18 0.24 0.26 0.27
Profit before tax 1.74 0.33 -1.18 -1.37 -1.75 -1.36 0.01 -0.21 -0.40 -1.79 -0.76 -2.08 -0.74
Tax % -0.00% 48.48% -0.00% -0.00% -0.00% 6.62% -0.00% -0.00% -0.00% -16.76% -0.00% -0.00% -0.00%
1.74 0.17 -1.18 -1.37 -1.75 -1.45 0.01 -0.22 -0.39 -1.49 -0.76 -2.08 -0.73
EPS in Rs 4.65 0.45 -3.15 -3.66 -4.68 -3.88 0.03 -0.59 -1.04 -3.98 -2.03 -5.56 -1.95
Raw PDF

Profit & Loss

Figures in Rs. Crores

Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025 TTM
-0.00 -0.00 -0.00 -0.00 11.89 11.99 20.92 26.17 18.24 15.39 11.02 28.20 13.63
0.02 0.02 0.05 0.05 10.81 10.88 19.15 22.74 15.67 13.14 14.39 27.94 16.23
Operating Profit -0.02 -0.02 -0.05 -0.05 1.08 1.11 1.77 3.43 2.57 2.25 -3.37 0.26 -2.60
OPM % 9.08% 9.26% 8.46% 13.11% 14.09% 14.62% -30.58% 0.92% -19.08%
0.06 0.06 0.06 0.06 0.05 0.05 0.10 0.09 0.06 0.04 0.05 -1.03 -1.14
Interest -0.00 -0.00 -0.00 -0.00 0.04 0.03 0.13 0.37 0.39 0.37 0.62 0.59 1.04
Depreciation -0.00 -0.00 -0.00 -0.00 1.09 1.03 1.01 1.94 1.93 1.88 1.71 1.03 0.59
Profit before tax 0.04 0.04 0.01 0.01 -0.00 0.10 0.73 1.21 0.31 0.04 -5.65 -2.39 -5.37
Tax % -0.00% 25.00% 200.00% 100.00% 20.00% 41.10% 38.02% 54.84% 375.00% 1.77% -12.55%
0.04 0.02 -0.00 -0.01 -0.00 0.08 0.43 0.75 0.14 -0.10 -5.75 -2.09 -5.06
EPS in Rs 0.10 0.05 -0.00 -0.03 -0.00 0.21 1.15 2.00 0.37 -0.27 -15.37 -5.59 -13.52
Dividend Payout % -0.00% -0.00% -0.00% -0.00% -0.00% -0.00% -0.00% -0.00% -0.00% -0.00%
Compounded Sales Growth
10 Years: %
5 Years: 6%
3 Years: 16%
TTM: -51%
Compounded Profit Growth
10 Years: %
5 Years: %
3 Years: %
TTM: -95%
Stock Price CAGR
10 Years: %
5 Years: 0%
3 Years: 0%
1 Year: -21%
Return on Equity
10 Years: %
5 Years: %
3 Years: %
Last Year: %

Balance Sheet

Figures in Rs. Crores

Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025 Sep 2025
Equity Capital 3.90 4.03 4.45 4.45 4.45 4.45 4.45 4.45 4.45 4.45 4.45 4.45 4.45
Reserves 0.09 0.12 0.11 0.10 0.11 0.18 0.61 1.37 1.51 1.40 -4.35 -6.44 -9.28
0.92 0.79 0.46 1.02 1.96 5.52 5.26 5.89 5.18 5.37 5.91 7.71 11.51
0.09 0.04 0.06 2.14 10.11 9.56 10.75 11.01 6.83 6.39 9.32 13.03 10.95
Total Liabilities 5.00 4.98 5.08 7.71 16.63 19.71 21.07 22.72 17.97 17.61 15.33 18.75 17.63
2.53 2.53 2.53 2.72 5.86 4.92 9.64 10.84 10.44 9.50 9.27 7.97 7.93
CWIP -0.00 -0.00 -0.00 -0.00 -0.00 3.33 -0.00 -0.00 -0.00 -0.00 0.10 -0.00 -0.00
Investments -0.00 -0.00 -0.00 -0.00 -0.00 0.20 0.20 0.20 -0.00 -0.00 -0.00 0.40 0.40
2.47 2.45 2.55 4.99 10.77 11.26 11.23 11.68 7.53 8.11 5.96 10.38 9.30
Total Assets 5.00 4.98 5.08 7.71 16.63 19.71 21.07 22.72 17.97 17.61 15.33 18.75 17.63

Cash Flows

Figures in Rs. Crores

Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025
-0.01 -0.06 -0.00 -0.50 3.88 0.92 2.82 3.53 0.75 0.33 -0.20 -0.96
-0.00 -0.00 -0.00 -0.19 -4.23 -3.41 -2.40 -3.15 -1.53 -0.94 -1.59 -0.70
0.01 -0.00 0.10 0.56 1.14 3.10 -0.23 0.40 -0.91 -0.04 1.43 1.40
Net Cash Flow -0.00 -0.06 0.09 -0.14 0.79 0.61 0.20 0.78 -1.69 -0.65 -0.36 -0.26

Ratios

Figures in Rs. Crores

Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025
Debtor Days 60.48 35.01 57.58 23.01 13.61 14.70 60.28 16.57
Inventory Days 203.34 278.66 88.17 107.27 154.80 286.55 123.74 56.09
Days Payable 609.39 645.07 311.84 269.40 299.82 309.82 382.60 173.18
Cash Conversion Cycle -345.57 -331.40 -166.09 -139.12 -131.41 -8.57 -198.58 -100.52
Working Capital Days -59.86 -71.84 -56.18 -48.26 -36.02 -0.47 -115.59 -40.38
ROCE % 0.82% 0.81% 0.20% 0.19% 0.66% 1.56% 8.40% 14.34% 6.13% 3.67% -58.39% -12.45%

Insights

In beta
Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Asset Status/Utilization Indicator (Revenue from Operations)
Rupees in Lacs

Log in to view insights

Please log in to see hidden values.

Login
Cost of Materials Consumed
Rupees in Lacs
Revenue from Labour Job Work
Rupees in Lacs
Employee Strength (On-Roll)
Number
Target New Product Launches
Number

Shareholding Pattern

Numbers in percentages

Mar 2023Jun 2023Sep 2023Dec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025
30.80% 30.80% 30.80% 30.80% 30.83% 30.80% 30.80% 30.80% 30.80% 30.80% 30.80% 30.80%
69.19% 69.20% 69.19% 69.19% 69.16% 69.19% 69.20% 69.20% 69.20% 69.21% 69.21% 69.20%
No. of Shareholders 1,9971,9781,9732,0022,0992,1852,2462,3342,3562,3772,3992,393

Documents